Kaempferol
- Half-Life (t½)
- PO: 4h
- Formula
- C15H10O6
- Molecular Weight
- 286.24 g/mol
- Aliases
- 3,4′,5,7-tetrahydroxyflavone
Pharmacological Mechanism
Flavonol with ER-α binding (weak phytoestrogen activity), Nrf2 activation, and mTOR inhibition. Gut-microbial conversion yields phloroglucinol-type metabolites. Anti-angiogenic effects reported in tumour models (VEGF pathway modulation).
Half-Life & Elimination Curve (PO: 4h)
Plasma (PO)t½ Decay (4h)
- 0×t½0h100% (0.959 µg/L)
- 1×t½4h50% (0.48 µg/L)
- 2×t½8h25% (0.24 µg/L)
- 3×t½12h12.5% (0.12 µg/L)
- 4×t½16h6.3% (0.0599 µg/L)
- 5×t½20h3.1% (0.03 µg/L)
Dosing Guidelines
- Oral (PO): Typical 6.67 mg (Range: 5–10 mg)
Pharmacokinetic Parameters
- Oral (PO): Bioavailability (F): 2% · Volume of Distribution (Vd): 84 L · Absorption (ka): 0.6 h⁻¹ (t½ka ≈ 1.16h) [PMID 19722166]
Pathways It Modulates
Target Organ Systems
Chemical Structure & Identifiers
- InChIKey: IYRMWMYZSQPJKC-UHFFFAOYSA-N
- SMILES: C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O
References